|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
Apr 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Geron+Corp+%28GERN%29+Posts+Q1+Loss+of+9cShare/8281248.html for the full story.
StreetInsider.com
Apr 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Geron+%28GERN%29+Issues+Update+on+Final+Results+from+Imetelstat+Phase+2/8241191.html for the full story.
Benzinga
Mar 14
Comment
Piper Jaffray downgraded Geron Corporation (NASDAQ: GERN) from Overweight to Neutral and lowered the price target from $3.00 to $1.50.
Piper Jaffray analyst Charles C. Duncan wrote, "Geron reported 4Q/FY12 earnings yesterday that were largely...
Benzinga
Mar 13
Comment
Stifel Nicolaus' Brian Klein downgraded shares of Geron (NASDAQ: GERN) from Hold to Sell in an intraday research note.
Related to Imetelstat rests trial, the analyst said, "While management states that this
is the most expedited way to derive...
StreetInsider.com
Mar 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Geron+Corp+%28GERN%29+Tops+Q4+Loss+Views%3B+Revs+Heavy/8180419.html for the full story.
Forbes
Feb 21
Comment
Michael Phelan is the CEO of SevOne. My Forbes colleague Tomio Geron recently wrote about his fast-growing IT company and Phelan contributed a guest post earlier this year at Eric Savitz's CIO Network.
Forbes
Jan 23
Comment
There's a lot to be said about the so-called "sharing economy." As Forbes' Tomio Geron explains in the current cover story, it isn't hard to make a connection between the current economy's scarcity of secure full-time work, and the appeal of...
Benzinga
Jan 18
Comment
Piper Jaffray initiated coverage on Geron Corporation (NASDAQ: GERN) with a Overweight rating and a $3.00 price target.
Piper Jaffray commented, "Geron is focused on developing drugs from its novel telomerase-inhibitor platform and its...
StreetInsider.com
Jan 17
Comment
American Greetings (NYSE: AM) 8% HIGHER; the Weiss Family disclosed they delivered letter to the Special Committee reiterating the Weiss Family’s Proposal and increasing the price offered per share in connection with the Proposal from $17.18 to...
Stock Blog Hub
Jan 16
Comment
Geron Corporation (GERN) announced that it has signed an Asset Contribution Agreement with BioTime, Inc. (BTX) and BioTime's recently formed subsidiary, BioTime Acquisition Corporation (BAC).
Per the terms of the agreement, Geron’s stem cell...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
